Thomas B. Neff, Chief Executive Officer at FIBROGEN INC (FGEN), sold 39,636 shares at $58.82 ($2.3M) on 2018-10-03, disclosed to the SEC on 2018-10-04.
Scheduled sale ($2.3M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.47 | 8,998 | $526K | 22.4% |
| 2 | $58.79 | 718 | $42K | 1.8% |
| 3 | $59.16 | 9,902 | $586K | 25.0% |
| 4 | $59.37 | 200 | $12K | 0.5% |
| 5 | $58.68 | 307 | $18K | 0.8% |
| 6 | $58.82 | 8,193 |
| $482K |
| 20.6% |
| 7 | $59.89 | 611 | $37K | 1.6% |
| 8 | $59.94 | 10,707 | $642K | 27.4% |
| Total | $59.15 avg | 39,636 | $2.3M | 100% |
| Filing → |
| FGEN | SELL | 2019-07-26 | $1.9M | — | Filing → |
| FGEN | SELL | 2019-07-12 | $1.8M | — | Filing → |
| FGEN | SELL | 2019-06-21 | $1.8M | — | Filing → |